- Home
- IINN vs ANTX Comparison
IINN vs ANTX Comparison
Compare IINN & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- ANTX
- Stock Information
- Founded
- IINN 2018
- ANTX 2017
- Country
- IINN Israel
- ANTX United States
- Employees
- IINN N/A
- ANTX N/A
- Industry
- IINN Medical/Dental Instruments
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- IINN Health Care
- ANTX Health Care
- Exchange
- IINN Nasdaq
- ANTX Nasdaq
- Market Cap
- IINN 34.1M
- ANTX 31.4M
- IPO Year
- IINN 2021
- ANTX 2022
- Fundamental
- Price
- IINN $1.17
- ANTX $1.24
- Analyst Decision
- IINN Strong Buy
- ANTX Buy
- Analyst Count
- IINN 1
- ANTX 2
- Target Price
- IINN $2.00
- ANTX $2.00
- AVG Volume (30 Days)
- IINN 1.6M
- ANTX 110.3K
- Earning Date
- IINN 11-14-2025
- ANTX 11-12-2025
- Dividend Yield
- IINN N/A
- ANTX N/A
- EPS Growth
- IINN N/A
- ANTX N/A
- EPS
- IINN N/A
- ANTX N/A
- Revenue
- IINN N/A
- ANTX N/A
- Revenue This Year
- IINN N/A
- ANTX N/A
- Revenue Next Year
- IINN $2,050.00
- ANTX N/A
- P/E Ratio
- IINN N/A
- ANTX N/A
- Revenue Growth
- IINN N/A
- ANTX N/A
- 52 Week Low
- IINN $0.40
- ANTX $0.98
- 52 Week High
- IINN $1.65
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- IINN 47.17
- ANTX 58.08
- Support Level
- IINN $1.13
- ANTX $1.05
- Resistance Level
- IINN $1.31
- ANTX $1.33
- Average True Range (ATR)
- IINN 0.08
- ANTX 0.08
- MACD
- IINN 0.00
- ANTX 0.01
- Stochastic Oscillator
- IINN 30.00
- ANTX 67.86
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.